C-type natriuretic peptide improves maternally aged oocytes quality by inhibiting excessive PINK1/Parkin-mediated mitophagy
eLife · 2023
DOI: 10.7554/elife.88523 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, 2023. Verfasst von Hui Zhang und 11 weiteren Autor:innen. Beteiligte Einrichtung: College of Veterinary Medicine, Northwest A&F University, Yangling, China. Hauptthemen laut MEDLINE: In Vitro Oocyte Maturation Techniques, Natriuretic Peptide, C-Type. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Postdoctoral Science Foundation of Shaanxi Province of China.
Abstract (Originalsprache)
The overall oocyte quality declines with aging, and this effect is strongly associated with a higher reactive oxygen species (ROS) level and the resultant oxidative damage. C-type natriuretic peptide (CNP) is a well-characterized physiological meiotic inhibitor that has been successfully used to improve immature oocyte quality during in vitro maturation. However, the underlying roles of CNP in maternally aged oocytes have not been reported. Here, we found that the age-related reduction in the serum CNP concentration was highly correlated with decreased oocyte quality. Treatment with exogenous CNP promoted follicle growth and ovulation in aged mice and enhanced meiotic competency and fertilization ability. Interestingly, the cytoplasmic maturation of aged oocytes was thoroughly improved by CNP treatment, as assessed by spindle/chromosome morphology and redistribution of organelles (mitochondria, the endoplasmic reticulum, cortical granules, and the Golgi apparatus). CNP treatment also ameliorated DNA damage and apoptosis caused by ROS accumulation in aged oocytes. Importantly, oocyte RNA-seq revealed that the beneficial effect of CNP on aged oocytes was mediated by restoration of mitochondrial oxidative phosphorylation, eliminating excessive mitophagy. CNP reversed the defective phenotypes in aged oocytes by alleviating oxidative damage and suppressing excessive PINK1/Parkin-mediated mitophagy. Mechanistically, CNP functioned as a cAMP/PKA pathway modulator to decrease PINK1 stability and inhibit Parkin recruitment. In summary, our results demonstrated that CNP supplementation constitutes an alternative therapeutic approach for advanced maternal age-related oocyte deterioration and may improve the overall success rates of clinically assisted reproduction in older women.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Veterinary Medicine, Northwest A&F University, Yangling, China.
- Key Laboratory of Animal Biotechnology, Ministry of Agriculture, Yangling, China.
ORCID-Profile: Jingmei Li, Baohua Ma
Förderung
- National Natural Science Foundation of China
- Postdoctoral Science Foundation of Shaanxi Province of China
Zitieren
APA
Zhang, H., Li, C., Liu, Q., Li, J., Wu, H., Xu, R., Sun, Y., Cheng, M., Zhao, X., Pan, M., Wei, Q., & Ma, B. (2023). C-type natriuretic peptide improves maternally aged oocytes quality by inhibiting excessive PINK1/Parkin-mediated mitophagy. eLife. https://doi.org/10.7554/elife.88523
Vancouver
Zhang H, Li C, Liu Q, Li J, Wu H, Xu R, et al. C-type natriuretic peptide improves maternally aged oocytes quality by inhibiting excessive PINK1/Parkin-mediated mitophagy. eLife. 2023. doi:10.7554/elife.88523
BibTeX
@article{Zhang2023,
author = {Zhang, Hui and Li, Chan and Liu, Qingyang and Li, Jingmei and Wu, Hao and Xu, Rui and Sun, Yidan and Cheng, Ming and Zhao, Xiaoe and Pan, Menghao and Wei, Qiang and Ma, Baohua},
title = {C-type natriuretic peptide improves maternally aged oocytes quality by inhibiting excessive PINK1/Parkin-mediated mitophagy},
journal = {eLife},
year = {2023},
doi = {10.7554/elife.88523}
}
EUVIMED